Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 HKD | 0.00% | -6.74% | -53.76% |
Jun. 07 | Transcenta Holding Limited Announces Directorate and Board Changes | CI |
May. 24 | Transcenta Shows 'Encouraging' Data from Gastric Cancer Combination Drug Trial | MT |
Sales 2024 * | 147M 20.25M 158M | Sales 2025 * | 160M 22.12M 173M | Capitalization | 624M 86.13M 673M |
---|---|---|---|---|---|
Net income 2024 * | -418M -57.68M -451M | Net income 2025 * | -413M -56.99M -445M | EV / Sales 2024 * | 5.77 x |
Net Debt 2024 * | 222M 30.68M 240M | Net cash position 2025 * | 455M 62.85M 491M | EV / Sales 2025 * | 1.05 x |
P/E ratio 2024 * |
-1.5
x | P/E ratio 2025 * |
-1.52
x | Employees | 215 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
1 week | -6.74% | ||
Current month | -6.74% | ||
1 month | -12.63% | ||
3 months | -24.55% | ||
6 months | -56.08% | ||
Current year | -53.76% |
Managers | Title | Age | Since |
---|---|---|---|
Xue Ming Qian
CEO | Chief Executive Officer | 57 | 10-07-31 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 21-12-16 |
Caroline Germa
CTO | Chief Tech/Sci/R&D Officer | 52 | 22-08-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Ming Qian
CEO | Chief Executive Officer | 57 | 10-07-31 |
Jia Song Tang
BRD | Director/Board Member | 50 | 21-09-13 |
Zhi Hua Zhang
BRD | Director/Board Member | 43 | 21-09-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.66 | 0.00% | 63,500 |
24-06-06 | 1.66 | +0.61% | 72,000 |
24-06-05 | 1.65 | -6.25% | 154,000 |
24-06-04 | 1.76 | -1.68% | 74,500 |
24-06-03 | 1.79 | +0.56% | 57,500 |
Delayed Quote Hong Kong S.E., June 07, 2024 at 04:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.76% | 86.14M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 6628 Stock